By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
Drugs in Development Information for Molidustat
Email this page to a colleague
What is the development status for investigational drug Molidustat?
Molidustat is an investigational drug.
There have been 9 clinical trials for Molidustat.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2017.
The most common disease conditions in clinical trials are Renal Insufficiency, Chronic, Renal Insufficiency, and Anemia. The leading clinical trial sponsors are Bayer and [disabled in preview].
There are seventeen US patents protecting this investigational drug and two hundred and seventy-four international patents.
Summary for Molidustat
| US Patents | 17 |
| International Patents | 274 |
| US Patent Applications | 40 |
| WIPO Patent Applications | 37 |
| Japanese Patent Applications | 9 |
| Clinical Trial Progress | Phase 2 (2017-12-01) |
| Vendors | 46 |
Recent Clinical Trials for Molidustat
| Title | Sponsor | Phase |
|---|---|---|
| Maintenance Treatment of Renal Anemia in Dialysis Subjects | Bayer | Phase 3 |
| A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects | Bayer | Phase 3 |
| A Study of Molidustat for Correction of Renal Anemia in Dialysis Subjects | Bayer | Phase 3 |
Clinical Trial Summary for Molidustat
Top disease conditions for Molidustat
Top clinical trial sponsors for Molidustat
US Patents for Molidustat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Molidustat | Get Started Free | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | Get Started Free |
| Molidustat | Get Started Free | Oral drug dosage forms having desired drug release profiles and uses thereof | Triastek, Inc. (Nanjing, CN) | Get Started Free |
| Molidustat | Get Started Free | Method for the preparation of triazole compounds | BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE) | Get Started Free |
| Molidustat | Get Started Free | Compartmented pharmaceutical dosage forms | Triastek, Inc. (Nanjing, CN) | Get Started Free |
| Molidustat | Get Started Free | Amide-substituted pyridinyltriazole derivatives and uses thereof | BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE) | Get Started Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Molidustat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Molidustat | Australia | AU2017261372 | 2036-05-05 | Get Started Free |
| Molidustat | Canada | CA3023278 | 2036-05-05 | Get Started Free |
| Molidustat | China | CN107847398 | 2036-05-05 | Get Started Free |
| Molidustat | European Patent Office | EP3452003 | 2036-05-05 | Get Started Free |
| Molidustat | Hong Kong | HK1249728 | 2036-05-05 | Get Started Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
